DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Anagnostis P, Athyros VG, Adamidou F. et al.
Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.
Diabetes Obes Metab 2011;
13: 302-312
We do not assume any responsibility for the contents of the web pages of other providers.